cFLIP regulation of lymphocyte activation and development

被引:231
作者
Budd, RC [1 ]
Yeh, WC
Tschopp, J
机构
[1] Univ Vermont, Dept Med, Program Immunol, Burlington, VT 05405 USA
[2] Univ Toronto, Cambell Family Inst Brest Canc Res, Univ Hlth Network, Dept Med Biophys, Toronto, ON M5G 2C1, Canada
[3] Univ Lausanne, Dept Biochem, BIL Biomed Res Ctr, CH-1066 Epalinges, Switzerland
基金
加拿大健康研究院; 美国国家卫生研究院;
关键词
D O I
10.1038/nri1787
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Cellular caspase-8 (FLICE)-like inhibitory protein (cFLIP) was originally identified as an inhibitor of death-receptor signalling through competition with caspase-8 for recruitment to FAS-associated via death domain ( FADD). More recently, it has been determined that both cFLIP and caspase-8 are required for the survival and proliferation of T cells following T-cell-receptor stimulation. This paradoxical finding launched new investigations of how these molecules might connect with signalling pathways that link to cell survival and growth following antigen-receptor activation. As discussed in this Review, insight gained from these studies indicates that cFLIP and caspase-8 form a heterodimer that ultimately links T-cell receptor signalling to activation of nuclear factor-kappa B through a complex that includes B-cell lymphoma 10 (BCL-10), mucosa-associated-lymphoid-tissue lymphoma-translocation gene 1 (MALT1) and receptor- interacting protein 1 (RIP1).
引用
收藏
页码:196 / 204
页数:9
相关论文
共 123 条
  • [1] Early activation of caspases during T lymphocyte stimulation results in selective substrate cleavage in nonapoptotic cells
    Alam, A
    Cohen, LY
    Aouad, S
    Sékaly, RP
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (12) : 1879 - 1890
  • [2] Phosphorylation of FADD at serine 194 by CKIα regulates its nonapoptotic activities
    Alappat, EC
    Feig, C
    Boyerinas, B
    Volkland, J
    Samuels, M
    Murmann, AE
    Thorburn, A
    Kidd, VJ
    Slaughter, CA
    Osborn, SL
    Winoto, A
    Tang, WJ
    Peter, ME
    [J]. MOLECULAR CELL, 2005, 19 (03) : 321 - 332
  • [3] FAS TRANSDUCES ACTIVATION SIGNALS IN NORMAL HUMAN T-LYMPHOCYTES
    ALDERSON, MR
    ARMITAGE, RJ
    MARASKOVSKY, E
    TOUGH, TW
    ROUX, E
    SCHOOLEY, K
    RAMSDELL, F
    LYNCH, DH
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (06) : 2231 - 2235
  • [4] Ashany D, 1999, J IMMUNOL, V163, P5303
  • [5] NF-κB-regulated expression of cellular FLIP protects rheumatoid arthritis synovial fibroblasts from tumor necrosis factor α-mediated apoptosis
    Bai, SC
    Liu, HT
    Chen, KH
    Eksarko, P
    Perlman, H
    Moore, TL
    Pope, RM
    [J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (12): : 3844 - 3855
  • [6] CD95 ligand induces motility and invasiveness of apoptosis-resistant tumor cells
    Barnhart, BC
    Legembre, P
    Pietras, E
    Bubici, C
    Franzoso, G
    Peter, ME
    [J]. EMBO JOURNAL, 2004, 23 (15) : 3175 - 3185
  • [7] p53 upregulates cFLIP, inhibits transcription of NF-κB-regulated genes and induces caspase-8-independent cell death in DLD-1 cells
    Bartke, T
    Siegmund, D
    Peters, N
    Reichwein, M
    Henkler, F
    Scheurich, P
    Wajant, H
    [J]. ONCOGENE, 2001, 20 (05) : 571 - 580
  • [8] The requirements for fas-associated death domain signaling in mature T cell activation and survival
    Beisner, DR
    Chu, IH
    Arechiga, AF
    Hedrick, SM
    Walsh, CM
    [J]. JOURNAL OF IMMUNOLOGY, 2003, 171 (01) : 247 - 256
  • [9] Death effector domain-containing herpesvirus and poxvirus proteins inhibit both Fas- and TNFR1-induced apoptosis
    Bertin, J
    Armstrong, RC
    Ottilie, S
    Martin, DA
    Wang, Y
    Banks, S
    Wang, GH
    Senkevich, TG
    Alnemri, ES
    Moss, B
    Lenardo, MJ
    Tomaselli, KJ
    Cohen, JI
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (04) : 1172 - 1176
  • [10] Differential sensitivity of endothelial cells of various species to apoptosis induced by gene transfer of Fas ligand:: Role of flip levels
    Bouchet, D
    Tesson, L
    Ménoret, S
    Charreau, B
    Mathieu, P
    Yagita, H
    Duisit, G
    Anegon, I
    [J]. MOLECULAR MEDICINE, 2002, 8 (10) : 612 - 623